Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma
- PMID: 11668133
- PMCID: PMC58536
- DOI: 10.1136/bmj.323.7318.896
Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma
Abstract
Objective: To determine the clinical effectiveness of pressurised metered dose inhalers (with or without spacer) compared with other hand held inhaler devices for the delivery of corticosteroids in stable asthma.
Design: Systematic review of randomised controlled trials.
Data sources: Cochrane Airways Group trials database (Medline, Embase, Cochrane controlled clinical trials register, and hand searching of 18 relevant journals), pharmaceutical companies, and bibliographies of included trials.
Trials: All trials in children or adults with stable asthma that compared a pressurised metered dose inhaler with any other hand held inhaler device delivering the same inhaled corticosteroid.
Results: 24 randomised controlled trials were included. Significant differences were found for forced expiratory volume in one second, morning peak expiratory flow rate, and use of drugs for additional relief with dry powder inhalers. However, either these were within clinically equivalent limits or the differences were not apparent once baseline characteristics had been taken into account. No significant differences were found between pressurised metered dose inhalers and any other hand held inhaler device for the following outcomes: lung function, symptoms, bronchial hyper-reactivity, systemic bioavailability, and use of additional relief bronchodilators.
Conclusions: No evidence was found that alternative inhaler devices (dry powder inhalers, breath actuated pressurised metered dose inhalers, or hydrofluoroalkane pressurised metered dose inhalers) are more effective than the pressurised metered dose inhalers for delivery of inhaled corticosteroids. Pressurised metered dose inhalers remain the most cost effective first line delivery devices.
Figures
Comment in
-
Review: pressurized metered-dose inhalers are as effective as other handheld inhalers for corticosteroid use in asthma.ACP J Club. 2002 May-Jun;136(3):110. doi: 10.7326/acpjc-2002-136-3-110. ACP J Club. 2002. PMID: 11985451 No abstract available.
-
Review: pressurised metered dose inhalers are as effective as other hand held inhalers for delivering corticosteroids in stable asthma.Evid Based Nurs. 2002 Apr;5(2):44-5. Evid Based Nurs. 2002. PMID: 11995647 No abstract available.
Similar articles
-
Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma.BMJ. 2001 Oct 20;323(7318):901-5. doi: 10.1136/bmj.323.7318.901. BMJ. 2001. PMID: 11668134 Free PMC article.
-
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260. Health Technol Assess. 2001. PMID: 11701099 Review.
-
Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma.Cochrane Database Syst Rev. 2002;2002(1):CD002158. doi: 10.1002/14651858.CD002158. Cochrane Database Syst Rev. 2002. PMID: 11869625 Free PMC article. Review.
-
Clinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials.Am J Respir Med. 2003;2(4):349-65. doi: 10.1007/BF03256663. Am J Respir Med. 2003. PMID: 14720001 Review.
-
Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2002;2002(1):CD002170. doi: 10.1002/14651858.CD002170. Cochrane Database Syst Rev. 2002. PMID: 11869627 Free PMC article. Review.
Cited by
-
Downstream Effects of Market Changes on Inhalers: Impacts on Individuals With Chronic Lung Disease.Respir Care. 2024 Oct 25;69(11):1448-1456. doi: 10.4187/respcare.12024. Respir Care. 2024. PMID: 39455252 Review.
-
The environmental impact of inhaler replacement: A carbon footprint and economic calculation of the National Database of Health Insurance Claims in Japan.J Gen Fam Med. 2023 Apr 11;24(4):207-214. doi: 10.1002/jgf2.622. eCollection 2023 Jul. J Gen Fam Med. 2023. PMID: 37484126 Free PMC article.
-
Evaluating inhaler education interventions for hospitalized children with asthma: A randomized controlled trial.Ann Allergy Asthma Immunol. 2023 Aug;131(2):217-223.e1. doi: 10.1016/j.anai.2023.02.023. Epub 2023 Mar 3. Ann Allergy Asthma Immunol. 2023. PMID: 36870528 Free PMC article. Clinical Trial.
-
An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease.J Taibah Univ Med Sci. 2023 Jan 12;18(4):860-867. doi: 10.1016/j.jtumed.2023.01.001. eCollection 2023 Aug. J Taibah Univ Med Sci. 2023. PMID: 36852239 Free PMC article.
-
Optimal follow-up period after switching to another inhaled corticosteroid/long-acting β2 agonist in patients with asthma: A retrospective study using Japanese administrative claims data.PLoS One. 2022 Oct 13;17(10):e0276001. doi: 10.1371/journal.pone.0276001. eCollection 2022. PLoS One. 2022. PMID: 36227895 Free PMC article.
References
-
- Clarke M, Oxman AD, editors. Review manager (RevMan) [computer program]. Version 4.1. Oxford: Cochrane Collaboration; 2000. Cochrane reviewers' handbook 4.0.
-
- Milanowski J, Qualtrough J, Perrin VL. Inhaled beclomethasone (BDP) with non-chlorofluorocarbon propellant (hydrofluoroalkane 134a) is equivalent to BDP-chlorofluorocarbon for the treatment of asthma. Respir Med. 1999;93:245–251. - PubMed
-
- Busse W, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Burgt JV, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol. 1999;104:1215–1222. - PubMed
-
- Vidgren P, Silvasti M, Poukkula A, Laasonen K, Vidgren M. Easyhaler powder inhaler—a new alternative in the anti-inflammatory treatment of asthma. Acta Therapeutica. 1994;20:117–131.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical